Israel Englander’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,000
Closed -$1.13M 6124
2024
Q2
$1.13M Sell
50,000
-154,500
-76% -$4.05M ﹤0.01% 4017
2024
Q1
$5.37M Buy
204,500
+79,500
+64% +$2.26M ﹤0.01% 2797
2023
Q4
$3.94M Buy
125,000
+75,000
+150% +$2.04M ﹤0.01% 2987
2023
Q3
$1.4M Sell
50,000
-512,500
-91% -$17.6M ﹤0.01% 3907
2023
Q2
$20.8M Buy
562,500
+450,000
+400% +$13.7M 0.01% 1358
2023
Q1
$3.37M Buy
+112,500
New +$3.71M ﹤0.01% 2957
2020
Q1
Sell
-20,000
Closed -$362K 3901
2019
Q4
$362K Buy
+20,000
New +$332K ﹤0.01% 3564

Other funds holding CC

Israel Englander's CC Position: Q2 2026 in Review

Israel Englander increased its Chemours (CC) stake by 29% in Q2 2026, buying an estimated $2.46M and bringing the position to 473,136 shares worth $9.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2308.

Israel Englander first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $196M in Q3 2017. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Israel Englander held 473,136 shares of Chemours worth $9.71M as of Q2 2026.
  • Israel Englander bought 107,632 Chemours shares in Q2 2026, an estimated $2.46M.
  • Chemours made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2308 holding.
  • Israel Englander first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
  • Israel Englander's Chemours position peaked at $196M in Q3 2017.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.